Dublin, Aug. 26, 2025 (GLOBE NEWSWIRE) -- The "Dementia - Global Clinical Trials Review, 2025" has been added to ResearchAndMarkets.com's offering.
This report offers a comprehensive examination of the global landscape of dementia clinical trials. The report consolidates crucial data, highlighting trial numbers, average enrollments in leading countries, and the geographical distribution of trials by region and country, including G7 and E7 nations. It classifies trials by phase, status, endpoints, and sponsor type and identifies leading drugs in ongoing trials.
Leveraging the analyst's exclusive Pharma Clinical Trials Database, the report synthesizes findings from over 80 sources worldwide. This continually updated database ensures the most current and reliable information.
The report is a significant tool, enhancing decision-making capabilities and aiding in developing effective counterstrategies to secure a competitive edge in the global market.
Report Scope:
- Provides an insight into the global clinical trials landscape.
- Details top-level data by region, country (G7 & E7), trial status, phase, sponsor type, and endpoint status.
- Lists key companies involved, with trial details including title, phase, and status.
- Includes information on uncompleted trials (terminated, suspended, withdrawn) with reasons.
- Analyzes enrollment trends over the past five years.
- Contains the latest news from the past three months.
Reasons to Buy:
- Aids in forming strategic investments and business strategies.
- Identifies optimal locations for conducting clinical trials, optimizing time and costs.
- Offers a top-level analysis of the Global Clinical Trials Market to pinpoint key business opportunities.
- Supports understanding of trial counts and enrollment trends across countries within the global therapeutics market.
- Facilitates interpretation of clinical trial success rates through comparisons of completed and uncompleted trials.
- Enhances assessment capabilities for indications at global, regional, and national levels.
A selection of companies mentioned in this report includes, but is not limited to:
- Eisai Co Ltd
- Johnson & Johnson
- Eli Lilly and Co
- Novartis AG
- C. H. Boehringer Sohn AG & Co KG
- Otsuka Holdings Co Ltd
- Thermo Fisher Scientific Inc
- Forest Laboratories LLC
- Teva Pharmaceutical Industries Ltd
- The Lundbeck Foundation
For more information about this clinical trials report visit https://www.researchandmarkets.com/r/1ccym
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
